Los Angeles Capital Management LLC Takes Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Los Angeles Capital Management LLC acquired a new stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 5,513 shares of the medical instruments supplier’s stock, valued at approximately $605,000. Los Angeles Capital Management LLC owned 0.10% of Mesa Laboratories at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of MLAB. Boone Capital Management LLC purchased a new position in shares of Mesa Laboratories during the 4th quarter valued at $6,712,000. Conestoga Capital Advisors LLC lifted its stake in shares of Mesa Laboratories by 9.1% during the 4th quarter. Conestoga Capital Advisors LLC now owns 578,463 shares of the medical instruments supplier’s stock valued at $60,606,000 after buying an additional 48,253 shares in the last quarter. Comerica Bank purchased a new position in shares of Mesa Laboratories during the 3rd quarter valued at $4,849,000. Glenmede Trust Co. NA lifted its stake in shares of Mesa Laboratories by 87.4% during the 3rd quarter. Glenmede Trust Co. NA now owns 94,337 shares of the medical instruments supplier’s stock valued at $9,912,000 after buying an additional 44,002 shares in the last quarter. Finally, Kennedy Capital Management LLC lifted its stake in Mesa Laboratories by 42.0% in the 3rd quarter. Kennedy Capital Management LLC now owns 109,496 shares of the medical instruments supplier’s stock worth $11,505,000 after purchasing an additional 32,412 shares in the last quarter. Hedge funds and other institutional investors own 90.60% of the company’s stock.

Mesa Laboratories Stock Down 1.3 %

Shares of MLAB stock opened at $89.94 on Wednesday. The stock has a market cap of $485.14 million, a P/E ratio of -1.91 and a beta of 0.86. Mesa Laboratories, Inc. has a 52 week low of $82.86 and a 52 week high of $145.46. The company has a quick ratio of 1.86, a current ratio of 0.37 and a debt-to-equity ratio of 0.58. The company’s fifty day simple moving average is $105.88 and its two-hundred day simple moving average is $103.42.

Mesa Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 14th. Shareholders of record on Friday, May 31st were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.71%. The ex-dividend date of this dividend was Friday, May 31st. Mesa Laboratories’s payout ratio is currently -1.36%.

Analyst Ratings Changes

Separately, Evercore ISI boosted their price target on shares of Mesa Laboratories from $124.00 to $130.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.